ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease

Li, Wenxin; Feng, Weijing; Su, Xiaoyan; Luo, Dongling; Li, Zhibing; Zhou, Yongqiao; Zhu, Yongjun; Zhang, Mengbi; Chen, Jie; Liu, Baohua; Huang, Hui*南方医科大学; 中山大学
Journal of Clinical Investigation2022-1-4DOI: 10.1172/JCI150051
47被引7阅读
引用收藏
分享

摘要

Vascular calcification (VC) is regarded as an important pathological change lacking effective treatment and associated with high mortality. Sirtuin 6 (SIRT6) is a member of the Sirtuin family, a class III histone deacetylase and a key epigenetic regulator. SIRT6 has a protective role in patients with chronic kidney disease (CKD). However, the exact role and molecular mechanism of SIRT6 in VC in patients with CKD remain unclear. Here, we demonstrated that SIRT6 was markedly downregulated in peripheral blood mononuclear cells (PBMCs) and in the radial artery tissue of patients with CKD with VC. SIRT6-transgenic (SIRT6-Tg) mice showed alleviated VC, while vascular smooth muscle cell-specific (VSMC-specific) SIRT6 knocked-down mice showed severe VC in CKD. SIRT6 suppressed the osteogenic transdifferentiation of VSMCs via regulation of runt-related transcription factor 2 (Runx2). Coimmunoprecipitation (co-IP) and immunoprecipitation (IP) assays confirmed that SIRT6 bound to Runx2. Moreover, Runx2 was deacetylated by SIRT6 and further promoted nuclear export via exportin 1 (XPO1), which in turn caused degradation of Runx2 through the ubiquitin-proteasome system. These results demonstrated that SIRT6 prevented VC by suppressing the osteogenic transdifferentiation of VSMCs, and as such targeting SIRT6 may be an appealing therapeutic target for VC in CKD.

学科与关键词

关键词
DNA-DAMAGECALCIFICATIONPROMOTESDIFFERENTIATIONACCUMULATIONACETYLATIONDEACETYLASEMECHANISMSEXPRESSIONDELETION
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Clinical Investigation
发表日期
2022-01-04
卷期
第 132 卷, 第 1 期
页码
e150051
DOI
10.1172/JCI150051
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Key Research and Development Program [2020YFC2004405]; National Natural Science Foundation of China [8201101103, 81870506, 91849208, 81670676, 81422011, 82073408]; Project of Traditional Chinese Medicine in Guangdong Province [20201062]; Basic Research Project of Shenzhen Science and Technology Innovation Committee [JCYJ20180306174648342, JCYJ20190808102005602]; Shenzhen Futian District Public Health Research Project [FTWS2019003]; Shenzhen Key Medical Discipline Construction Fund [SZXK002]; Dongguan Social Science and Technology Development Project [2018507150461629]

作者

  • L

    Li, Wenxin (第一作者)

    sun yat sen univ

  • F

    Feng, Weijing

    southern med univ

查看全部 11 位作者收起作者
  • S

    Su, Xiaoyan

    sun yat sen univ

  • L

    Luo, Dongling

    sun yat sen univ

  • L

    Li, Zhibing

    sun yat sen univ

  • Z

    Zhou, Yongqiao

    sun yat sen univ

  • Z

    Zhu, Yongjun

    sun yat sen univ

  • Z

    Zhang, Mengbi

    sun yat sen univ

  • C

    Chen, Jie

    sun yat sen univ

  • L

    Liu, Baohua

    shenzhen univ

  • H

    Huang, Hui (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417